(image: Philips International B.V.)
Amsterdam, the Netherlands and Milan, Italy, Apr. 25 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced IntelliSpace Radiation Oncology [1], an intelligent patient management solution to manage complexity, improve efficiency and enable operational excellence in radiotherapy departments. IntelliSpace Radiation Oncology provides a harmonized way of working, integrating applications and automating workflow to help reduce the amount of time it takes from receiving a patient referral to the start of their treatment. The solution is being unveiled at the European Society for Radiation Oncology’s (ESTRO) 38th Annual Meeting in Milan, Italy on Friday April 26, 2019.
Radiotherapy is an important and cost-effective part of cancer treatment and control. More than half of all cancer types can be treated with radiotherapy [2], often in combination with other types of therapy such as surgery and chemotherapy. However, radiotherapy is often perceived as a complex treatment option due to the number of clinical specialists and advanced technologies required to deliver effective care. IntelliSpace Radiation Oncology is designed to manage this complexity by providing an integrated platform that connects all the steps from the patient’s referral to the start of their treatment.
“By integrating all of the steps in the radiotherapy department’s workflow into one platform, IntelliSpace Radiation Oncology is designed to improve communication and harmonize ways of working across clinical teams, improving the consistency of care they provide,” said Ardie Ermers, General Manager Radiation Oncology, Philips. “Each step of the patient’s journey is captured, providing a strong basis for automating workflows, enhancing efficiency and operational excellence.”
IntelliSpace Radiation Oncology is flexible and can be customized to the specific needs of a department and each clinician. It is an open, vendor-agnostic platform designed to provide comprehensive interoperability across the hospital IT environment.
To support healthcare providers in capitalizing on the insights and workflow improvement opportunities presented by the platform, Philips is also launching Radiation Oncology Practice Management [1]. This consultancy service will support radiotherapy departments in identifying and acting on data-driven insights to achieve operational excellence.
IntelliSpace Radiation Oncology is the latest addition to Philips’ renewed suite of radiation oncology systems and software. On show for the first time at ESTRO, the new portfolio includes Pinnacle Evolution treatment planning software, Big Bore RT, a dedicated oncology CT simulator, and the Ingenia Elition 3.0T MR-RT and Ambition 1.5T MR-RT systems.
At the show Philips also announced that it plans to expand its leading MR-only radiotherapy simulation portfolio with MRCAT brain [3]. Based on a single, fast MR scan and leveraging AI, Philips’ MRCAT brain will be designed to automatically generate CT-like density information on the MR console. Philips’ MR-only simulation technology, which also includes MRCAT pelvis and prostate, enables clinicians to rely on a single imaging modality by providing both MR’s superior soft-tissue contrast for delineation and density information for dose calculations.
Partnering for integrated imaging, planning and treatment
Philips’ strong partnerships across imaging, planning and treatment support increased precision and clinical confidence to help clinicians deliver the best possible care. In January 2019, Philips announced a collaboration with imaging solutions provider MIM Software Inc. (Cleveland, US), a company that provides practical imaging, automation, and data analysis solutions to radiation therapy clinics worldwide. Philips also has an ongoing collaboration with Sun Nuclear to integrate its suite of PlanIQ™ software into Pinnacle Evolution.
Philips’ collaboration with Elekta (Stockholm, Sweden), a leader in precision radiation medicine has resulted in the introduction of the Elekta Unity, the world’s first high-field MR-linac (linear accelerator). Philips also has a long-standing partnership with IBA (Ion Beam Applications S.A, Louvain-La-Neuve, Belgium), a leading provider of proton beam therapy systems.
Visit Philips at booth #4000 at ESTRO 38. For more information about Philips’ presence at the show, including the full suite of Philips radiation oncology technology and integrated solutions, visit Philips’ ESTRO event website and follow @PhilipsLiveFrom for updates throughout #ESTRO38.
[1] IntelliSpace Radiation Oncology and Radiation Oncology Practice Management are considered works in progress and not available for sale.
[2] https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/radiation/basics.html.
[3] MRCAT brain is considered work in progress, is not CE marked and is not available for sale or distribution.
For further information, please contact:
Mark Groves
Philips Group Press Office
Tel: +31 631 639 916
Email: mark.groves@philips.com
Twitter: mark_groves
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
- Philips_IntelliSpace_Radiation_Oncology
- Philips_IntelliSpace_Radiation_Oncology_Dialog
- Philips_MRCAT_brain
Source: Philips International B.V. via GLOBE NEWSWIRE
